| Hazard ratio associated with progression to type 2 diabetes between 12 months from referral and 31st March 2020 | |
---|---|---|
 | Unadjusted | Adjusted |
Attended 2 sessions | 1.005 | 1.020 |
 | [0.864,1.169] | [0.876,1.187] |
Attended 3 sessions | 0.880 | 0.881 |
 | [0.756,1.023] | [0.755,1.027] |
Attended 4 sessions | 0.978 | 0.976 |
 | [0.851,1.124] | [0.845,1.126] |
Attended 5 sessions | 0.849* | 0.879 |
 | [0.730,0.988] | [0.754,1.026] |
Attended 6 sessions | 0.842* | 0.886 |
 | [0.723,0.980] | [0.760,1.034] |
Attended 7 sessions | 0.723*** | 0.782** |
 | [0.615,0.849] | [0.664,0.921] |
Attended 8 sessions | 0.684*** | 0.749*** |
 | [0.581,0.807] | [0.633,0.886] |
Attended 9 sessions | 0.663*** | 0.755*** |
 | [0.565,0.780] | [0.641,0.891] |
Attended 10 sessions | 0.571*** | 0.680*** |
 | [0.486,0.669] | [0.577,0.801] |
Attended 11 sessions | 0.504*** | 0.630*** |
 | [0.433,0.587] | [0.538,0.737] |
Attended 12 sessions | 0.405*** | 0.511*** |
 | [0.345,0.475] | [0.433,0.602] |
Attended 13 sessions | 0.419*** | 0.545*** |
 | [0.352,0.498] | [0.455,0.652] |
Observations | 51,803 | 51,803 |